New Website to Aid Align's Growth - Analyst Blog
February 21 2013 - 8:10AM
Zacks
In a continuous attempt to
penetrate the huge untapped malocclusion market, Align
Technologies (ALGN) recently came up with the strategy to
expand through educational offerings. The company launched an
interactive website that provides professional education resources
for Invisalign providers.
As a part of the company’s
password-protected portal –Invisalign Doctor Site, this new
educational offering will help the company identify the doctors
individually and provide educational content and suggestions based
on the geographic location of the doctors, the relevant Invisalign
product and treatment option meeting their needs.
Align has tremendous growth
opportunities in the malocclusion market. It is estimated that
malocclusion affects roughly a billion individuals
worldwide. Out of this, approximately 6.8 million people
annually elect treatment by orthodontists worldwide. Further, 2.6
million people have mild-to-moderate malocclusion and are eligible
for Invisalign treatment.
Owing to compromised aesthetics,
discomfort and other drawbacks associated with traditional
orthodontic treatments, a relatively small number of people with
malocclusion seek treatment. As a result, the market is severely
under penetrated.
Realizing the fact that it can
increase market share by tapping the under-penetrated market, Align
has undertaken several strategies to improve the adoption of
Invisalign that includes product/technology development, extending
clinical effectiveness, extension of the Invisalign brand and
driving international growth.
The company is quite optimistic
about the acceptance of Invisalign i7 in UK across GP and Ortho
channels. Moreover, Invisalign Teen utilization trend in France is
encouraging. China and Japan, Align’s latest direct country
markets, are also exhibiting strong growth.In China, the launch of
Invisalign during the second quarter of 2011 was followed by the
introduction of Invisalign 4 and Invisalign Teen in that
region.
Align believes that the new
features and functionality delivered with Invisalign G3 and G4 are
even more effective outside North America, especially in Asia, due
to the higher complexity of cases among the Asian population. Over
the long term, we expect G4 and similar other innovations to act as
major catalysts to maintain Align’s growth momentum in new as well
as existing markets.
The stock currently carries a Zacks
Rank #3 (Hold). Other medical device stocks worth a look are
Medical Action Industries Inc. (MDCI),
Given Imaging Ltd. (GIVN) and Acadia
Health Company Inc. (ACHC). All these stocks carry a Zacks
Rank #1 (Strong Buy).
ACADIA HEALTHCR (ACHC): Free Stock Analysis Report
ALIGN TECH INC (ALGN): Free Stock Analysis Report
GIVEN IMAGING (GIVN): Free Stock Analysis Report
MEDICAL ACTION (MDCI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Given Imaging (NASDAQ:GIVN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Given Imaging (NASDAQ:GIVN)
Historical Stock Chart
From Aug 2023 to Aug 2024